Summary of Action
October 27th, 2020
Between 2015 and 2019, multiple class-action lawsuits were filed against Quincy Bioscience for falsely advertising the brain supplement Prevagen to
Browsing the "prevagen" Tag
Status and Updates
October 27th, 2020
October 27, 2020: TINA.org files brief as amicus curiae opposing the proposed settlement reached by the parties, as well as
Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection
October 27th, 2020
Pending class-action settlement leaves consumers behind.
Prevagen Products
August 20th, 2020
July 2020: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for November 17, 2020.
Quincy Bioscience’s Prevagen Supplement
August 20th, 2020
July 2020: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for November 17, 2020.
Prevagen Supplement
August 20th, 2020
July 2020: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for November 17, 2020.
Prevagen Dietary Supplements
August 20th, 2020
July 2020: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for November 17, 2020.
Quincy Bioscience’s Prevagen
August 20th, 2020
July 2020: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for November 17, 2020.
Prevagen Is Going to the Dogs
February 22nd, 2019
Second Circuit rules FTC/NY case against Prevagen can proceed.
Prevagen Memory Study Falls Short
March 9th, 2018
TINA.org, AARP and others file legal brief urging court to reverse dismissal of Prevagen case.
Status and Updates
March 7th, 2018
February 21, 2019: The Second Circuit Court of Appeals issued a Summary Order vacating the District Court’s judgment and remanding
Summary of Action
March 7th, 2018
Prompted by a TINA.org investigation and complaint, the Federal Trade Commission, together with the New York Attorney General, filed a lawsuit
Prevagen Supplements
January 10th, 2017
A false advertising class-action lawsuit against Quincy Bioscience was dismissed in June 2016. The complaint, which was originally filed in
Prevagen’s Fishy Memory Claims Under Fire by Federal Regulators
January 9th, 2017
Five things you should know about the FTC, New York lawsuit against Prevagen.
Ad Watchdog Calls Out Broadcast Networks for Airing Deceptive Ads
January 19th, 2016
TINA.org Urges Better Screening MADISON, CONN., January 19, 2016 – Consumer advocacy organization, truthinadvertising.org (TINA.org), has put major broadcast networks
TINA.org Alerts Major TV Networks to Deceptive Prevagen Ads
January 19th, 2016
TINA.org also calls on the BBB to re-evaluate company's A-plus rating.
FTC Complaint Filed Against Maker of Memory Supplement
September 21st, 2015
Ad Watchdog Issues Warning to Consumers MADISON, CONN. September 21, 2015 — With an aging baby-boomer population and an estimated
Prevagen Studies
September 20th, 2015
The Effects of the Calcium Binding Protein Apoaequorin on Memory and Cognitive Functioning in Older Adults Impact of Prevagen on
TINA.org to FTC: Prevagen is Making Unsupported Memory Claims
September 20th, 2015
Investigation finds no competent evidence to support memory improvement claims and FTC files a lawsuit.
12
